{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:22:55Z","timestamp":1792740175099,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2923-B-002-001-MY3"],"award-info":[{"award-number":["112-2923-B-002-001-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["114-CTC0012"],"award-info":[{"award-number":["114-CTC0012"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["115-CTC0016"],"award-info":[{"award-number":["115-CTC0016"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rpth.2026.103423","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:27:30Z","timestamp":1774546050000},"page":"103423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic strategies in intracerebral hemorrhage: from hematoma stabilization to alleviating secondary brain injury"],"prefix":"10.1016","volume":"10","author":[{"given":"Pei-Feng","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-1468","authenticated-orcid":false,"given":"Hsin-Hsi","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.103423_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","article-title":"Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis","volume":"9","author":"van Asch","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib2","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/STROKEAHA.121.037751","article-title":"Brain peri-hematomal area, a strategic interface for blood clearance: a human neuropathological and transcriptomic study","volume":"53","author":"Puy","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib3","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103423_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","article-title":"Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial","volume":"19","author":"Meretoja","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1474-4422(24)00128-5","article-title":"Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial","volume":"23","author":"Yassi","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib6","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103423_bib7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaneurol.2019.2636","article-title":"Effect of recombinant activated coagulation factor VII on hemorrhage expansion among patients with spot sign-positive acute intracerebral hemorrhage: the SPOTLIGHT and STOP-IT randomized clinical trials","volume":"76","author":"Gladstone","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib8","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103423_bib9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib10","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJMoa2313040","article-title":"Andexanet for factor Xa inhibitor-associated acute intracerebral hemorrhage","volume":"390","author":"Connolly","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103423_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1747-4949.2011.00761.x","article-title":"Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC)","volume":"8","author":"Gonzales","year":"2013","journal-title":"Int J Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jama.2023.16893","article-title":"Remote ischemic conditioning for acute stroke: the RESIST randomized clinical trial","volume":"330","author":"Blauenfeldt","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2026.103423_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1474-4422(19)30069-9","article-title":"Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial","volume":"18","author":"Selim","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-103776","article-title":"Mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH): protocol for a prospective, randomised, open-label, blinded-endpoint phase IIb trial","volume":"15","author":"Krishnan","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.rpth.2026.103423_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101666","article-title":"Efficacy and safety of glibenclamide therapy after intracerebral haemorrhage (GATE-ICH): a multicentre, prospective, randomised, controlled, open-label, blinded-endpoint, phase 2 clinical trial","volume":"53","author":"Zhao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.rpth.2026.103423_bib16","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/STROKEAHA.117.018658","article-title":"Minocycline in acute cerebral hemorrhage: an early phase randomized trial","volume":"48","author":"Fouda","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ene.13403","article-title":"Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study","volume":"24","author":"Chang","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13063-023-07371-4","article-title":"Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial","volume":"24","author":"Voigt","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.rpth.2026.103423_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/23969873231185208","article-title":"Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH)","volume":"8","author":"Parry-Jones","year":"2023","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.rpth.2026.103423_bib20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/ene.12140","article-title":"Effects of celecoxib on hematoma and edema volumes in primary intracerebral hemorrhage: a multicenter randomized controlled trial","volume":"20","author":"Lee","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(05)70233-6","article-title":"Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial","volume":"365","author":"Mendelow","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103423_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(13)60986-1","article-title":"Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial","volume":"382","author":"Mendelow","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103423_bib23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S1474-4422(16)30234-4","article-title":"Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial","volume":"15","author":"Hanley","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(19)30195-3","article-title":"Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial","volume":"393","author":"Hanley","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103423_bib25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2308440","article-title":"Trial of early minimally invasive removal of intracerebral hemorrhage","volume":"390","author":"Pradilla","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103423_bib26","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0140-6736(24)00702-5","article-title":"Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial","volume":"403","author":"Beck","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103423_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(16)32410-2","article-title":"Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial","volume":"389","author":"Hanley","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103423_bib28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41582-024-01035-w","article-title":"Intracerebral haemorrhage \u2013 mechanisms, diagnosis and prospects for treatment and prevention","volume":"20","author":"Seiffge","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib29","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","article-title":"Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage","volume":"368","author":"Anderson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103423_bib30","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in patients with acute cerebral hemorrhage","volume":"375","author":"Qureshi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103423_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(23)00806-1","article-title":"The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial","volume":"402","author":"Ma","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103423_bib32","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2314741","article-title":"Intensive ambulance-delivered blood-pressure reduction in hyperacute stroke","volume":"390","author":"Li","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103423_bib33","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/STROKEAHA.118.022133","article-title":"Increased blood pressure variability contributes to worse outcome after intracerebral hemorrhage","volume":"49","author":"de Havenon","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1474-4422(25)00160-7","article-title":"Effects of blood pressure lowering in relation to time in acute intracerebral haemorrhage: a pooled analysis of the four INTERACT trials","volume":"24","author":"Wang","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib35","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/23969873251340815","article-title":"European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage","volume":"10","author":"Steiner","year":"2025","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.rpth.2026.103423_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamaneurol.2025.0586","article-title":"Acute blood pressure lowering and risk of ischemic lesions on MRI after intracerebral hemorrhage","volume":"82","author":"Butcher","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib38","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/17474930211042700","article-title":"Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): protocol for a phase III, double-blind, randomized, placebo-controlled trial","volume":"17","author":"Naidech","year":"2022","journal-title":"Int J Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/brain\/aws349","article-title":"Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study","volume":"136","author":"B\u00e9jot","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.rpth.2026.103423_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/23969873211005915","article-title":"Variation in medical management and neurosurgical treatment of patients with supratentorial spontaneous intracerebral haemorrhage","volume":"6","author":"Sondag","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.rpth.2026.103423_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1474-4422(23)00157-6","article-title":"Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial","volume":"22","author":"Desborough","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib42","article-title":"Quality of chronic anticoagulation control in patients with intracranial haemorrhage due to vitamin K antagonists","volume":"2018","author":"Estevez-Fraga","year":"2018","journal-title":"Stroke Res Treat"},{"key":"10.1016\/j.rpth.2026.103423_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100107","article-title":"Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing","volume":"7","author":"Chiasakul","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103423_bib44","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1161\/STROKEAHA.123.042866","article-title":"Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): a multicenter, randomized, placebo-controlled, phase 2 trial","volume":"54","author":"Polymeris","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal \u2013 full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103423_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.25732","article-title":"Neurosurgical intervention for supratentorial intracerebral hemorrhage","volume":"88","author":"Sondag","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41016-022-00288-y","article-title":"Conventional craniotomy versus conservative treatment in patients with minor spontaneous intracerebral hemorrhage in the basal ganglia","volume":"8","author":"Wang","year":"2022","journal-title":"Chin Neurosurg J"},{"key":"10.1016\/j.rpth.2026.103423_bib48","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209714","article-title":"Surgical management for primary intracerebral hemorrhage","volume":"103","author":"Morris","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.rpth.2026.103423_bib49","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jocn.2013.03.022","article-title":"Minimally invasive surgery for primary supratentorial intracerebral haemorrhage","volume":"20","author":"Ramanan","year":"2013","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.rpth.2026.103423_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12916-024-03468-y","article-title":"Minimally invasive surgeries for spontaneous hypertensive intracerebral hemorrhage (MISICH): a multicenter randomized controlled trial","volume":"22","author":"Xu","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.rpth.2026.103423_bib51","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1161\/STROKEAHA.124.048650","article-title":"Outcomes following minimally invasive surgery for intracerebral hemorrhage in the AHA get with the guidelines-stroke registry","volume":"56","author":"Murthy","year":"2025","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jocn.2023.11.003","article-title":"Minimally invasive endoscopic evacuation with the novel, portable Axonpen neuroendoscopic system for spontaneous intracerebral hemorrhage","volume":"119","author":"Lee","year":"2024","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.rpth.2026.103423_bib53","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.STR.0000063367.52044.40","article-title":"Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA)","volume":"34","author":"Teernstra","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103880","article-title":"Novel targets, treatments, and advanced models for intracerebral haemorrhage","volume":"76","author":"Zille","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.rpth.2026.103423_bib55","article-title":"Erythrophagocytosis by microglia\/macrophage in intracerebral hemorrhage: from mechanisms to translation","volume":"16","author":"Liu","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.rpth.2026.103423_bib56","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/STROKEAHA.119.027037","article-title":"Bexarotene enhances macrophage erythrophagocytosis and hematoma clearance in experimental intracerebral hemorrhage","volume":"51","author":"Chang","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib57","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1084\/jem.20171905","article-title":"Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulation","volume":"215","author":"Vaibhav","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.rpth.2026.103423_bib58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/23969873231201712","article-title":"Safety and efficacy of remote ischemic conditioning for spontaneous intracerebral hemorrhage (SERIC-ICH): a multicenter, randomized, parallel-controlled clinical trial study design and protocol","volume":"9","author":"Guo","year":"2024","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.rpth.2026.103423_bib59","article-title":"Iron neurotoxicity and protection by deferoxamine in intracerebral hemorrhage","volume":"15","author":"Li","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.rpth.2026.103423_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/523652","article-title":"The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging","volume":"2013","author":"Thomsen","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.rpth.2026.103423_bib61","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12975-017-0535-5","article-title":"CD163, a hemoglobin\/haptoglobin scavenger receptor, after intracerebral hemorrhage: functions in microglia\/macrophages versus neurons","volume":"8","author":"Garton","year":"2017","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.rpth.2026.103423_bib62","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.08.013","article-title":"CD163\/hemoglobin oxygenase-1 pathway regulates inflammation in hematoma surrounding tissues after intracerebral hemorrhage","volume":"24","author":"Liu","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.rpth.2026.103423_bib63","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fneur.2018.00682","article-title":"Research progress in understanding the relationship between heme oxygenase-1 and intracerebral hemorrhage","volume":"9","author":"Li","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib64","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/STROKEAHA.121.037834","article-title":"Functional investigation of meningeal lymphatic system in experimental intracerebral hemorrhage","volume":"53","author":"Tsai","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib65","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s12028-021-01311-3","article-title":"Neuroprotective therapies for spontaneous intracerebral hemorrhage","volume":"35","author":"Kearns","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.rpth.2026.103423_bib66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/WCO.0000000000001325","article-title":"New targets in spontaneous intracerebral hemorrhage","volume":"38","author":"Chiang","year":"2025","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3340\/jkns.2007.42.4.337","article-title":"Accumulated mannitol and aggravated cerebral edema in a rat model of middle cerebral artery infarction","volume":"42","author":"Cho","year":"2007","journal-title":"J Korean Neurosurg Soc"},{"key":"10.1016\/j.rpth.2026.103423_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105948","article-title":"Brain edema formation and therapy after intracerebral hemorrhage","volume":"176","author":"Wan","year":"2023","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.rpth.2026.103423_bib69","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/STROKEAHA.115.009357","article-title":"Mannitol and outcome in intracerebral hemorrhage: propensity score and multivariable intensive blood pressure reduction in acute cerebral hemorrhage trial 2 results","volume":"46","author":"Wang","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib70","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.wneu.2018.11.249","article-title":"The effect of mannitol in the early stage of supratentorial hypertensive intracerebral hemorrhage: a systematic review and meta-analysis","volume":"124","author":"Sun","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.rpth.2026.103423_bib71","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S1474-4422(24)00425-3","article-title":"Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial","volume":"23","author":"Sheth","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5853\/jos.2019.02236","article-title":"Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets","volume":"22","author":"Tschoe","year":"2020","journal-title":"J Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033464","article-title":"Minocycline in severe cerebral amyloid angiopathy: a single-center cohort study","volume":"13","author":"Bax","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rpth.2026.103423_bib74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/23969873231200686","article-title":"Anakinra in cerebral haemorrhage to target secondary injury resulting from neuroinflammation (ACTION): study protocol of a phase II randomised clinical trial","volume":"9","author":"Cliteur","year":"2024","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.rpth.2026.103423_bib75","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamaneurol.2014.1065","article-title":"Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study","volume":"71","author":"Fu","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib76","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/acn3.70163","article-title":"Effects of non-aspirin nonsteroidal anti-inflammatory drugs on acute intracerebral hemorrhage","volume":"12","author":"Yeh","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.rpth.2026.103423_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12028-007-0081-1","article-title":"An association of prior statin use with decreased perihematomal edema","volume":"8","author":"Naval","year":"2008","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.rpth.2026.103423_bib78","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/jcbfm.2015.36","article-title":"Perihematoma cerebral blood flow is unaffected by statin use in acute intracerebral hemorrhage patients","volume":"35","author":"Gioia","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.rpth.2026.103423_bib79","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/STROKEAHA.120.029345","article-title":"Impact of statins on hematoma, edema, seizures, vascular events, and functional recovery after intracerebral hemorrhage","volume":"52","author":"Spr\u00fcgel","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.935198","article-title":"Edaravone use in acute intracerebral hemorrhage: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Qin","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rpth.2026.103423_bib81","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/STROKEAHA.120.032266","article-title":"Reactive oxygen species scavenger in acute intracerebral hemorrhage patients: a multicenter, randomized controlled trial","volume":"52","author":"Kim","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147228","article-title":"MicroNAR-194-5p hinders the activation of NLRP3 inflammasomes and alleviates neuroinflammation during intracerebral hemorrhage by blocking the interaction between TRAF6 and NLRP3","volume":"1752","author":"Wan","year":"2021","journal-title":"Brain Res"},{"key":"10.1016\/j.rpth.2026.103423_bib83","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.05.027","article-title":"M2 monocyte microparticles are increased in intracerebral hemorrhage","volume":"26","author":"Walsh","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.rpth.2026.103423_bib84","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/STROKEAHA.111.639989","article-title":"\u03b17 nicotinic acetylcholine receptor agonism confers neuroprotection through GSK-3beta inhibition in a mouse model of intracerebral hemorrhage","volume":"43","author":"Krafft","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib85","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12975-017-0559-x","article-title":"Melatonin alleviates intracerebral hemorrhage-induced secondary brain injury in rats via suppressing apoptosis, inflammation, oxidative stress, DNA damage, and mitochondria injury","volume":"9","author":"Wang","year":"2018","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.rpth.2026.103423_bib86","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.jcbfm.9600213","article-title":"Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement","volume":"26","author":"Lee","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.rpth.2026.103423_bib87","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.STR.0000163053.77982.8d","article-title":"Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies","volume":"36","author":"Haley","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.103423_bib88","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1166\/jnn.2021.18668","article-title":"Influence of nanoparticle-loaded edaravone on postoperative effects in patients with cerebral hemorrhage","volume":"21","author":"Dang","year":"2021","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.rpth.2026.103423_bib89","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.3892\/etm.2016.3811","article-title":"Cell therapy for cerebral hemorrhage: five year follow-up report","volume":"12","author":"Chang","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.rpth.2026.103423_bib90","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/318269","article-title":"Efficacy of surgery combined with autologous bone marrow stromal cell transplantation for treatment of intracerebral hemorrhage","volume":"2015","author":"Zhu","year":"2015","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.rpth.2026.103423_bib91","doi-asserted-by":"crossref","first-page":"8294","DOI":"10.4238\/2014.October.20.5","article-title":"Curative effect and safety of intrathecal transplantation of neural stem cells for the treatment of cerebral hemorrhage","volume":"13","author":"Xue","year":"2014","journal-title":"Genet Mol Res"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:17:33Z","timestamp":1790723853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926000816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2475037926000816"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103423","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic strategies in intracerebral hemorrhage: from hematoma stabilization to alleviating secondary brain injury","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103423"}}